Human Plasma Samples
Central BioHub offers Human Plasma Samples in different qualities. So you can clearly see, if a biospecimen is for instance haemolytic or in perfect condition. We offer ACD, Citrate, CPD, CPDA, EDTA, K2 EDTA, K3 EDTA, Na EDTA, Heparin, NaHep, LiHep, K Oxalate and NaF Plasma. To meet your Research and Developement (R&D) needs use further filtering and customize your search for example by laboratory parameters, disease in clear name or ICD-10 code, donor specifications, quantity and price. If you do not find the sample you are looking for, please contact us.
5,000 Products
Human EDTA plasma - Alkaline Phosphatase (ALP), Bilirubin... - C25.0
- Donor:
- Gender: Female Age: 59
- Diagnosed disease:
- C25.0 - Malignant neoplasm of head of pancreas - T2, N0, M0, stage IIA, resectable (not specified)
- Medication:
- Addel
- Parameter:
- Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Hemoglobin (Hb) Lipase Pancreatic Amylase
Donor:
- Gender:
- Female
- Age:
- 59 Years
- BMI:
- 24.8 kg/m²
- Weight:
- 70 kg
- Height:
- 168 cm
Sample:
- Matrix:
- EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of head of pancreas [C25.0] - T2, N0, M0, stage IIA, resectable (not specified)
Medication:
- Addel
- Aminoven
- Cernevit
- L-thyroxine
- Meronem
- Pantozol
- bisoprolol
- lercanidipine
- metoclopramide
- potassium
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual: positive
Quant: 283 U/L
Source: this donation
|
35-104 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual: positive
Quant: 10.2 mg/dl
Source: this donation
|
< 1 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual: positive
Quant: 216.1 U/mL
Source: this donation
|
< 27 U/mL
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) |
Qual: positive
Quant: 183 U/L
Source: this donation
|
Jun 42 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamate pyruvate transaminase (GPT / ALAT, ALT) |
Qual: positive
Quant: 61 U/L
Source: this donation
|
Okt 35 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamic oxaloacetic transaminase (GOT / ASAT / AST) |
Qual: positive
Quant: 49 U/L
Source: this donation
|
Okt 35 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Hemoglobin (Hb) |
Qual:
Quant: 10.5 g/dl
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Lipase |
Qual: negative
Quant: 41 U/L
Source: this donation
|
13 - 60 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Pancreatic Amylase |
Qual: negative
Quant: 32 U/L
Source: this donation
|
13 - 53 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308237
0.4 mL ($17.25)
Human EDTA plasma - Alkaline Phosphatase (ALP), Amylase, ... - C24.0
- Donor:
- Gender: Female Age: 78
- Diagnosed disease:
- C24.0 - Malignant neoplasm of extrahepatic bile duct - T3, N1, M0, stage IIB, resectable (not specified)
- Medication:
- Fenistil
- Parameter:
- Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) ...
Donor:
- Gender:
- Female
- Age:
- 78 Years
- BMI:
- 24.3 kg/m²
- Weight:
- 67 kg
- Height:
- 166 cm
Sample:
- Matrix:
- EDTA plasma
- Condition:
- icteric
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of extrahepatic bile duct [C24.0] - T3, N1, M0, stage IIB, resectable (not specified)
Medication:
- Fenistil (Fenistil dry)
- L-thyroxine (Dosages: 25not specified)
- Ramipril (Dosages: 5not specified)
- hydrochlorothiazide (HCT) (Dosages: 25not specified)
- pantoprazole (Dosages: 40not specified)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual:
Quant: 299 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Amylase |
Qual:
Quant: 214 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual:
Quant: 12.02 mg/dl
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual:
Quant: 0.8 not specified
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) |
Qual:
Quant: 164 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glucose |
Qual:
Quant: 92 mg/dl
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamate pyruvate transaminase (GPT / ALAT, ALT) |
Qual:
Quant: 235 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamic oxaloacetic transaminase (GOT / ASAT / AST) |
Qual:
Quant: 110 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 37 mmol/mol
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Hemoglobin (Hb) |
Qual:
Quant: 13.9 g/dl
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Lipase |
Qual:
Quant: 703 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308307
0.4 mL ($17.25)
Human EDTA plasma - Alkaline Phosphatase (ALP), Amylase, ... - K43.2
- Donor:
- Gender: Male Age: 52
- Medication:
- Enbrel
- Parameter:
- Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Hemoglobin (Hb) Lipase ...
Donor:
- Gender:
- Male
- Age:
- 52 Years
- BMI:
- 28.1 kg/m²
- Weight:
- 91 kg
- Height:
- 180 cm
Sample:
- Matrix:
- EDTA plasma
- Condition:
- hemolytic
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Medication:
- Enbrel
- Metoprolol (Dosages: 47not specified)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual:
Quant: 78 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Amylase |
Qual:
Quant: 39 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual: negative
Quant: 0.37 mg/dl
Source: this donation
|
< 1.2 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual: negative
Quant: 16.6 U/mL
Source: this donation
|
< 27 U/mL
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) |
Qual: positive
Quant: 256 U/L
Source: this donation
|
< 61 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glucose |
Qual: negative
Quant: 88 mg/dl
Source: this donation
|
60 - 110 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamate pyruvate transaminase (GPT / ALAT, ALT) |
Qual:
Quant: 43 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamic oxaloacetic transaminase (GOT / ASAT / AST) |
Qual:
Quant: 47 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Hemoglobin (Hb) |
Qual: negative
Quant: 14.3 g/dl
Source: this donation
|
12.5-17.2 g/dl
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Lipase |
Qual: negative
Quant: 22 U/L
Source: this donation
|
13-60 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308143
0.4 mL ($17.25)
Human EDTA plasma - Alkaline Phosphatase (ALP), Amylase, ... - C25.0
- Donor:
- Gender: Male Age: 75
- Medication:
- Vitalux
- Parameter:
- Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) ...
Donor:
- Gender:
- Male
- Age:
- 75 Years
- BMI:
- 27.2 kg/m²
- Weight:
- 90 kg
- Height:
- 182 cm
Sample:
- Matrix:
- EDTA plasma
- Condition:
- icteric
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Medication:
- Vitalux
- metformin
- salbutamol
- simvastatine
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual:
Quant: 191 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Amylase |
Qual:
Quant: 58 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual: positive
Quant: 8.35 mg/dl
Source: this donation
|
< 1.2 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual: positive
Quant: 29.6 U/mL
Source: this donation
|
< 27 U/mL
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) |
Qual: positive
Quant: 373 U/L
Source: this donation
|
< 61 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glucose |
Qual: positive
Quant: 131 mg/dl
Source: this donation
|
60 - 110 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamate pyruvate transaminase (GPT / ALAT, ALT) |
Qual:
Quant: 241 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamic oxaloacetic transaminase (GOT / ASAT / AST) |
Qual:
Quant: 99 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 40 mmol/mol
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Hemoglobin (Hb) |
Qual: negative
Quant: 12.9 g/dl
Source: this donation
|
12.5-17.2 g/dl
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Lipase |
Qual: positive
Quant: 89 U/L
Source: this donation
|
13-60 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH307960
0.4 mL ($17.25)
Human EDTA plasma - Alkaline Phosphatase (ALP), Amylase, ... - K86.1
- Donor:
- Gender: Female Age: 34
- Medication:
- Novaminsulfon
- Parameter:
- Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase ...
Donor:
- Gender:
- Female
- Age:
- 34 Years
- BMI:
- 20.9 kg/m²
- Weight:
- 64 kg
- Height:
- 175 cm
Sample:
- Matrix:
- EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 1
Medication:
- Novaminsulfon
- Pantozol
- Panzytrat
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual:
Quant: 72 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Amylase |
Qual:
Quant: 99 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual: negative
Quant: 0.54 mg/dl
Source: this donation
|
< 1.2 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual: negative
Quant: 17.9 U/mL
Source: this donation
|
< 27 U/mL
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) |
Qual: positive
Quant: 38 U/L
Source: this donation
|
< 36 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamate pyruvate transaminase (GPT / ALAT, ALT) |
Qual:
Quant: 17 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamic oxaloacetic transaminase (GOT / ASAT / AST) |
Qual:
Quant: 18 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 25 mmol/mol
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Hemoglobin (Hb) |
Qual: negative
Quant: 14.2 g/dl
Source: this donation
|
11.8 -15.8 g/dl
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Lipase |
Qual: positive
Quant: 77 U/L
Source: this donation
|
13-60 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308035
0.3 mL ($12.94)
Human EDTA plasma - Alkaline Phosphatase (ALP), Bilirubin... - C25.0
- Donor:
- Gender: Male Age: 69
- Diagnosed disease:
- C25.0 - Malignant neoplasm of head of pancreas - T2, N1, M0, stage IIB, resectable (not specified)
- Medication:
- Fenistil
- Parameter:
- Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase ...
Donor:
- Gender:
- Male
- Age:
- 69 Years
- BMI:
- 24 kg/m²
- Weight:
- 76 kg
- Height:
- 178 cm
Sample:
- Matrix:
- EDTA plasma
- Condition:
- icteric
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of head of pancreas [C25.0] - T2, N1, M0, stage IIB, resectable (not specified)
Medication:
- Fenistil
- Metohexal
- Pantozol
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual: positive
Quant: 314 U/L
Source: this donation
|
40-129 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual: positive
Quant: 20.9 mg/dl
Source: this donation
|
< 1 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual: positive
Quant: 993.3 U/mL
Source: this donation
|
< 27 U/mL
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) |
Qual: positive
Quant: 82 U/L
Source: this donation
|
Okt 71 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glucose |
Qual: positive
Quant: 114 mg/dl
Source: this donation
|
74 - 106 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamate pyruvate transaminase (GPT / ALAT, ALT) |
Qual: positive
Quant: 129 U/L
Source: this donation
|
Okt 50 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamic oxaloacetic transaminase (GOT / ASAT / AST) |
Qual: positive
Quant: 104 U/L
Source: this donation
|
Okt 50 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 43 mmol/mol
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Hemoglobin (Hb) |
Qual:
Quant: 12.9 g/dl
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Lipase |
Qual: negative
Quant: 21 U/L
Source: this donation
|
13 - 60 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Pancreatic Amylase |
Qual: positive
Quant: 9 U/L
Source: this donation
|
13 - 53 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308259
0.5 mL ($21.56)
Human EDTA plasma - Cancer-Antigen 19-9 (CA 19-9), Hemogl... - C25.2
- Donor:
- Gender: Male Age: 82
- Diagnosed disease:
- C25.2 - Malignant neoplasm of tail of pancreas - T3, N0, M1, stage IV, non-resectable (not specified)
- Medication:
- Sortis
- Parameter:
- Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Hemoglobin (Hb) Lipase Pancreatic Amylase
Donor:
- Gender:
- Male
- Age:
- 82 Years
- BMI:
- 25.3 kg/m²
- Weight:
- 73 kg
- Height:
- 170 cm
Sample:
- Matrix:
- EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of tail of pancreas [C25.2] - T3, N0, M1, stage IV, non-resectable (not specified)
Medication:
- Sortis
- amlodipine
Therapy:
- transplant
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual: negative
Quant: 75 U/L
Source: this donation
|
40-129 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual: negative
Quant: 0.5 mg/dl
Source: this donation
|
< 1 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual: positive
Quant: 407.8 U/mL
Source: this donation
|
< 27 U/mL
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) |
Qual: negative
Quant: 49 U/L
Source: this donation
|
Okt 71 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamate pyruvate transaminase (GPT / ALAT, ALT) |
Qual: negative
Quant: 24 U/L
Source: this donation
|
Okt 50 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamic oxaloacetic transaminase (GOT / ASAT / AST) |
Qual: negative
Quant: 31 U/L
Source: this donation
|
Okt 50 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Hemoglobin (Hb) |
Qual:
Quant: 14.7 g/dl
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Lipase |
Qual: negative
Quant: 22 U/L
Source: this donation
|
13 - 60 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Pancreatic Amylase |
Qual: positive
Quant: 12 U/L
Source: this donation
|
13 - 53 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308273
0.5 mL ($21.56)
Human K3EDTA plasma - Anti-cyclic citrullinated Peptide (CC... - D50.9
- Donor:
- Gender: Female Age: 58 Ethnic group: European/Caucasian
- Medication:
- Metex
- Parameter:
- Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total Rheumatoid Factor (tRF)
Donor:
- Gender:
- Female
- Age:
- 58 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 23 kg/m²
- Weight:
- 68 kg
- Height:
- 172 cm
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 1
Medication:
- Metex (Dosages: 17.5mg/week)
- Orencia (Dosages: 25mg/week, active agent: abatacept)
- Tardyferon
- escitalopram (Dosages: 10mg/day)
- folic acid (Dosages: 5mg/week)
- rosuvastatin (Dosages: 20mg/day)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) |
Qual: positive
Quant: > 500.00 IU/mL
Source: previous donation
|
< 17.00 IU/mL
|
Method: not specified System: Cobas Roche |
| Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG |
Qual: positive
Quant: > 500.00 U/mL
Source: this donation
|
< 17.00 U/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: Cobas 8000 Roche |
| Capsule-reactive protein (CRP) |
Qual: negative
Quant: 3.71 mg/L
Source: this donation
|
< 5.00 mg/L
|
Method: not specified System: Modular Roche |
| Capsule-reactive protein (CRP) |
Qual: negative
Quant: 4.1 mg/L
Source: this donation
|
< 5.00 mg/L
|
Method: TIA (Turbidimetric Immuno Assay) System: Cobas 8000 Roche |
| Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) |
Qual:
Quant: 21 mm/1h
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Rheumatoid Factor (RF) IgM |
Qual: positive
Quant: 21 IU/mL
Source: this donation
|
< 15.00 IU/mL
|
Method: TIA (Turbidimetric Immuno Assay) System: Cobas 8000 Roche |
| Total Rheumatoid Factor (tRF) |
Qual: positive
Quant: 16 IU/mL
Source: this donation
|
< 14.00 IU/mL
|
Method: not specified System: Modular Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH292278
1 mL ($43.13)
Human K3EDTA plasma - Capsule-reactive protein (CRP), Capsu... - I10.90
- Donor:
- Gender: Female Age: 73 Ethnic group: European/Caucasian
- Diagnosed disease:
- I10.90
- Medication:
- Brimica
- Parameter:
- Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total Rheumatoid Factor (tRF)
Donor:
- Gender:
- Female
- Age:
- 73 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 28 kg/m²
- Weight:
- 65.3 kg
- Height:
- 154 cm
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 1
Diseases:
- I10.90
Medication:
- Brimica
- Ibuflam (Dosages: 800mg/day, active agent: ibuprofen)
- Quensyl (active agent: hydroxychloroquine)
- Tevanate (Dosages: 70mg/week)
- Vigantoletten (Dosages: 1000IU/day)
- leflunomide (Dosages: 10mg/day)
- pantoprazole (Dosages: 20mg/day)
- salbutamol (as needed)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG |
Qual: negative
Quant: < 7.00 U/mL
Source: this donation
|
< 17.00 U/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: Cobas 8000 Roche |
| Capsule-reactive protein (CRP) |
Qual: positive
Quant: 6.86 mg/L
Source: this donation
|
< 5.00 mg/L
|
Method: not specified System: Modular Roche |
| Capsule-reactive protein (CRP) |
Qual: positive
Quant: 7.1 mg/L
Source: this donation
|
< 5.00 mg/L
|
Method: TIA (Turbidimetric Immuno Assay) System: Cobas 8000 Roche |
| Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) |
Qual:
Quant: 38 mm/1h
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Rheumatoid Factor (RF) IgM |
Qual: negative
Quant: 11 IU/mL
Source: this donation
|
< 15.00 IU/mL
|
Method: TIA (Turbidimetric Immuno Assay) System: Cobas 8000 Roche |
| Total Rheumatoid Factor (tRF) |
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
|
< 14.00 IU/mL
|
Method: not specified System: Modular Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH295903
1 mL ($43.13)
Human K3EDTA plasma - Capsule-reactive protein (CRP), Capsu... - C18.6
- Donor:
- Gender: Male Age: 66 Ethnic group: European/Caucasian
- Diagnosed disease:
- C18.6 - Malignant neoplasm of descending colon
- Medication:
- Hygroton
- Parameter:
- Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total Rheumatoid Factor (tRF)
Donor:
- Gender:
- Male
- Age:
- 66 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 34 kg/m²
- Weight:
- 104 kg
- Height:
- 176 cm
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 1
Diseases:
- Malignant neoplasm of descending colon [C18.6]
Medication:
- Hygroton (Dosages: 25mg/day, active agent: chlorthalidone)
- Metex (Dosages: 125mg/week)
- Prednisolon (Dosages: 2mg/day)
- Simvabeta (Dosages: 10mg/day)
- amlodipine (Dosages: 5mg/day)
- bisoprolol (Dosages: 5mg/day)
- hydroxychloroquine (Dosages: 400/day)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) |
Qual: negative
Quant: < 8.00 IU/mL
Source: this donation
|
< 17.00 IU/mL
|
Method: not specified System: Cobas Roche |
| Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG |
Qual: negative
Quant: < 7.00 U/mL
Source: this donation
|
< 17.00 U/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: Cobas 8000 Roche |
| Capsule-reactive protein (CRP) |
Qual: positive
Quant: 27.2 mg/L
Source: this donation
|
< 5.00 mg/L
|
Method: TIA (Turbidimetric Immuno Assay) System: Cobas 8000 Roche |
| Capsule-reactive protein (CRP) |
Qual: positive
Quant: 34.37 mg/L
Source: this donation
|
< 5.00 mg/L
|
Method: not specified System: Modular Roche |
| Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) |
Qual:
Quant: 29 mm/1h
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Rheumatoid Factor (RF) IgM |
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
|
< 15.00 IU/mL
|
Method: TIA (Turbidimetric Immuno Assay) System: Cobas 8000 Roche |
| Total Rheumatoid Factor (tRF) |
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
|
< 14.00 IU/mL
|
Method: not specified System: Modular Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH292431
1 mL ($43.13)
Human K3EDTA plasma - Anti-cyclic citrullinated Peptide (CC... - E11.90
- Donor:
- Gender: Female Age: 75 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90
- Medication:
- Humalog
- Parameter:
- Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total IgM Total Rheumatoid Factor (tRF)
Donor:
- Gender:
- Female
- Age:
- 75 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 26 kg/m²
- Weight:
- 70 kg
- Height:
- 164 cm
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 1
Diseases:
- E11.90
Medication:
- Humalog (active agent: insulin lispro)
- Lantus (active agent: insulin glargin)
- Metex (Dosages: 20mg/week)
- Orencia (Dosages: 750mg/4 weeks, active agent: abatacept)
- Prednisolon (Dosages: 1mg, as needed)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG |
Qual: positive
Quant: 33 U/mL
Source: this donation
|
< 17.00 U/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: Cobas 8000 Roche |
| Capsule-reactive protein (CRP) |
Qual: negative
Quant: 4.71 mg/L
Source: this donation
|
< 5.00 mg/L
|
Method: not specified System: Modular Roche |
| Capsule-reactive protein (CRP) |
Qual: positive
Quant: 6.1 mg/L
Source: this donation
|
< 5.00 mg/L
|
Method: TIA (Turbidimetric Immuno Assay) System: Cobas 8000 Roche |
| Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) |
Qual:
Quant: 35 mm/1h
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Rheumatoid Factor (RF) IgM |
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
|
< 15.00 IU/mL
|
Method: TIA (Turbidimetric Immuno Assay) System: Cobas 8000 Roche |
| Total IgM |
Qual: positive
Quant: 32 mg/dl
Source: this donation
|
40.00 - 230.00 mg/dl
|
Method: TIA (Turbidimetric Immuno Assay) System: Cobas 8000 Roche |
| Total Rheumatoid Factor (tRF) |
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
|
< 14.00 IU/mL
|
Method: not specified System: Modular Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH295179
1 mL ($43.13)
Human K3EDTA plasma - Anti-cyclic citrullinated Peptide (CC... - M05.80
- Donor:
- Gender: Female Age: 31 Ethnic group: European/Caucasian
- Medication:
- Ferro Sanol
- Parameter:
- Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total Rheumatoid Factor (tRF)
Donor:
- Gender:
- Female
- Age:
- 31 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 22 kg/m²
- Weight:
- 70 kg
- Height:
- 178 cm
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 1
Medication:
- Ferro Sanol (daily)
- Metex (Dosages: 15mg/week)
- Prednisolon (Dosages: 7.5mg/day)
- Vigantoletten (Dosages: 1000IU/day)
- folic acid (Dosages: 5mg/week)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) |
Qual: positive
Quant: 202 IU/mL
Source: previous donation
|
< 17.00 IU/mL
|
Method: not specified System: Cobas Roche |
| Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG |
Qual: positive
Quant: 205 U/mL
Source: this donation
|
< 17.00 U/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: Cobas 8000 Roche |
| Capsule-reactive protein (CRP) |
Qual: negative
Quant: 3.3 mg/L
Source: this donation
|
< 5.00 mg/L
|
Method: TIA (Turbidimetric Immuno Assay) System: Cobas 8000 Roche |
| Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) |
Qual:
Quant: 17 mm/1h
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Rheumatoid Factor (RF) IgM |
Qual: positive
Quant: 62 IU/mL
Source: this donation
|
< 15.00 IU/mL
|
Method: TIA (Turbidimetric Immuno Assay) System: Cobas 8000 Roche |
| Total Rheumatoid Factor (tRF) |
Qual: positive
Quant: 73 IU/mL
Source: previous donation
|
< 14.00 IU/mL
|
Method: not specified System: Modular Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH292230
1 mL ($43.13)
Human K3EDTA plasma - Erythrocyte sedimentation rate (ESR) ... - M05.80
- Donor:
- Gender: Female Age: 49 Ethnic group: European/Caucasian
- Medication:
- Folsan
- Parameter:
- Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total Rheumatoid Factor (tRF)
Donor:
- Gender:
- Female
- Age:
- 49 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 26 kg/m²
- Weight:
- 70 kg
- Height:
- 165 cm
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 1
Medication:
- Folsan (Dosages: 5mg/week, active agent: folic acid)
- Metex (Dosages: 17.5mg/week)
- Orencia (Dosages: 125mg/week, active agent: abatacept)
- Prednisolon (as needed)
- Vigantoletten (Dosages: 1000IU/day)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG |
Qual: negative
Quant: 11 U/mL
Source: this donation
|
< 17.00 U/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: Cobas 8000 Roche |
| Capsule-reactive protein (CRP) |
Qual: negative
Quant: 1.06 mg/L
Source: this donation
|
< 5.00 mg/L
|
Method: not specified System: Modular Roche |
| Capsule-reactive protein (CRP) |
Qual: negative
Quant: 2 mg/L
Source: this donation
|
< 5.00 mg/L
|
Method: TIA (Turbidimetric Immuno Assay) System: Cobas 8000 Roche |
| Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) |
Qual:
Quant: 35 mm/1h
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Rheumatoid Factor (RF) IgM |
Qual: positive
Quant: 57 IU/mL
Source: this donation
|
< 15.00 IU/mL
|
Method: TIA (Turbidimetric Immuno Assay) System: Cobas 8000 Roche |
| Total Rheumatoid Factor (tRF) |
Qual: positive
Quant: 64 IU/mL
Source: this donation
|
< 14.00 IU/mL
|
Method: not specified System: Modular Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH295897
1 mL ($43.13)
Human K3EDTA plasma - Erythrocyte sedimentation rate (ESR) ... - E07.9
- Donor:
- Gender: Female Age: 63 Ethnic group: European/Caucasian
- Diagnosed disease:
- E07.9 - Disorder of thyroid, unspecified
- Medication:
- Prednisolon
- Parameter:
- Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total IgM Total Rheumatoid Factor (tRF)
Donor:
- Gender:
- Female
- Age:
- 63 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 46 kg/m²
- Weight:
- 116 kg
- Height:
- 159 cm
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- slightly turbid
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 1
Diseases:
- Disorder of thyroid, unspecified [E07.9]
Medication:
- Prednisolon (Dosages: 8mg/day)
- Vigantoletten (Dosages: 1000IU/day)
- leflunomide (Dosages: 10mg/day)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG |
Qual: negative
Quant: < 7.00 U/mL
Source: this donation
|
< 17.00 U/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: Cobas 8000 Roche |
| Capsule-reactive protein (CRP) |
Qual: negative
Quant: 2.2 mg/L
Source: this donation
|
< 5.00 mg/L
|
Method: TIA (Turbidimetric Immuno Assay) System: Cobas 8000 Roche |
| Capsule-reactive protein (CRP) |
Qual: negative
Quant: 4.64 mg/L
Source: previous donation
|
< 5.00 mg/L
|
Method: not specified System: Modular Roche |
| Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) |
Qual:
Quant: 29 mm/1h
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Rheumatoid Factor (RF) IgM |
Qual: negative
Quant: 12 IU/mL
Source: this donation
|
< 15.00 IU/mL
|
Method: TIA (Turbidimetric Immuno Assay) System: Cobas 8000 Roche |
| Total IgM |
Qual: negative
Quant: 40 mg/dl
Source: this donation
|
40.00 - 230.00 mg/dl
|
Method: TIA (Turbidimetric Immuno Assay) System: Cobas 8000 Roche |
| Total Rheumatoid Factor (tRF) |
Qual: negative
Quant: 10 IU/mL
Source: previous donation
|
< 14.00 IU/mL
|
Method: not specified System: Modular Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH233874
0.4 mL ($17.25)
Human EDTA plasma - Alkaline Phosphatase (ALP), Amylase, ... - C25.0
- Donor:
- Gender: Male Age: 70
- Diagnosed disease:
- C25.0 - Malignant neoplasm of head of pancreas - T2, N1, M0, stage IIB, resectable (not specified)
- Medication:
- omeprazole
- Parameter:
- Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase ...
Donor:
- Gender:
- Male
- Age:
- 70 Years
- BMI:
- 23.7 kg/m²
- Weight:
- 70 kg
- Height:
- 172 cm
Sample:
- Matrix:
- EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of head of pancreas [C25.0] - T2, N1, M0, stage IIB, resectable (not specified)
- arterial hypertension
- diarrhea
- normochromic anemia
- pancreas carcinoma - ductal. Adenocarcinoma (not specified)
Medication:
- omeprazole (Dosages: 40not specified)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual:
Quant: 75 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Amylase |
Qual:
Quant: 6 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual:
Quant: 0.37 mg/dl
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual:
Quant: 27 not specified
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) |
Qual:
Quant: 25 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamate pyruvate transaminase (GPT / ALAT, ALT) |
Qual:
Quant: 18 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamic oxaloacetic transaminase (GOT / ASAT / AST) |
Qual:
Quant: 21 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 34 mmol/mol
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Hemoglobin (Hb) |
Qual:
Quant: 13.5 g/dl
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Lipase |
Qual:
Quant: 16 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308309
0.4 mL ($17.25)
Human EDTA plasma - Glutamic oxaloacetic transaminase (GO... - K86.0
- Donor:
- Gender: Male Age: 51
- Medication:
- Kreon
- Parameter:
- Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase Pancreatic Amylase ...
Donor:
- Gender:
- Male
- Age:
- 51 Years
- BMI:
- 30 kg/m²
- Weight:
- 92 kg
- Height:
- 175 cm
Sample:
- Matrix:
- EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Medication:
- Kreon
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual: negative
Quant: 99 U/L
Source: this donation
|
40-129 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual: negative
Quant: 0.7 mg/dl
Source: this donation
|
< 1 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual: negative
Quant: 8.9 U/mL
Source: this donation
|
< 27 U/mL
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) |
Qual: negative
Quant: 30 U/L
Source: this donation
|
Okt 71 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamate pyruvate transaminase (GPT / ALAT, ALT) |
Qual: negative
Quant: 18 U/L
Source: this donation
|
Okt 50 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamic oxaloacetic transaminase (GOT / ASAT / AST) |
Qual: positive
Quant: 8 U/L
Source: this donation
|
Okt 50 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 40 mmol/mol
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Hemoglobin (Hb) |
Qual:
Quant: 14.5 g/dl
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Lipase |
Qual: negative
Quant: 28 U/L
Source: this donation
|
13 - 60 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Pancreatic Amylase |
Qual: negative
Quant: 32 U/L
Source: this donation
|
13 - 53 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308281
0.5 mL ($21.56)
Human K2EDTA plasma - Anti-Thyroid peroxidase (aTPO / MAK),... - E05.0
- Donor:
- Gender: Female Age: 40 Ethnic group: European/Caucasian
- Diagnosed disease:
- E89.0 - Postprocedural hypothyroidism
- Medication:
- L-thyroxine
- Parameter:
- Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH)
Donor:
- Gender:
- Female
- Age:
- 40 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 24.51 kg/m²
- Blood type:
- Not specified
- Rhesus factor:
- not specified
- Weight:
- 70 kg
- Height:
- 169 cm
Sample:
- Matrix:
- K2EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Thyrotoxicosis with diffuse goitre [E05.0]
- Postprocedural hypothyroidism [E89.0]
Medication:
- L-thyroxine (Dosages: 100not specified)
- calcium (Dosages: 500mg)
Therapy:
- thyroid surgery
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual: positive
Quant: 144 kIU/L
Source: previous donation
|
< 34.00 kIU/L
|
Method: not specified System: Cobas Modular Roche |
| TSH Receptor Antibodies (TRAb) |
Qual: positive
Quant: 2.34 IU/L
Source: previous donation
|
< 1.22 IU/L
|
Method: not specified System: Cobas Modular Roche |
| Thyrotropin (TSH) |
Qual: negative
Quant: 3.53 mU/L
Source: this donation
Remarks: sensitive |
0.270 - 4.200 mU/L
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: Cobas 8000 e-Module Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH330562
1 mL ($43.13)
Human K3EDTA plasma - Glycosylated hemoglobin (HbA1, HbA1c) - E11.40
- Donor:
- Gender: Male Age: 55 Ethnic group: European/Caucasian
- Diagnosed disease:
- I10.90
- Medication:
- Aldactone
- Parameter:
- Glycosylated hemoglobin (HbA1, HbA1c)
Donor:
- Gender:
- Male
- Age:
- 55 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 33 kg/m²
- Blood type:
- Not specified
- Rhesus factor:
- not specified
- Weight:
- 125 kg
- Height:
- 196 cm
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- E11.40
- Postprocedural hypothyroidism [E89.0]
- I10.90
Medication:
- Aldactone (Dosages: 25not specified, active agent: spironolactone)
- Atozet
- Hygroton (Dosages: 25not specified, active agent: chlorthalidone)
- Jardiance (Dosages: 10mg)
- L-Thyrox (Dosages: 150not specified)
- allopurinol (Dosages: 100not specified)
- amlodipine (Dosages: 5mg)
- insulin
- metformin
- no incretin mimetics
- valsartan (Dosages: 80mg)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual: positive
Quant: 10.1 %
Source: this donation
|
4.00 - 6.00 %
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH344377
1 mL ($43.13)
Human K2EDTA plasma - C73
- Donor:
- Gender: Male Age: 59 Ethnic group: European/Caucasian
- Diagnosed disease:
- I10.90
- Medication:
- L-thyroxine
- Parameter:
- Anti-Thyroglobulin (aTg / TAK)
Donor:
- Gender:
- Male
- Age:
- 59 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 35 kg/m²
- Blood type:
- Not specified
- Rhesus factor:
- not specified
- Weight:
- 115 kg
- Height:
- 182 cm
Sample:
- Matrix:
- K2EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- C73
- Postprocedural hypothyroidism [E89.0]
- I10.90
Medication:
- L-thyroxine (Dosages: 150not specified)
- Ramipril (Dosages: 10mg)
- amlodipine (Dosages: 5mg)
- atorvastatin (Dosages: 20mg)
- pramipexole (Dosages: 0.7mg)
Therapy:
- thyroid surgery
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroglobulin (aTg / TAK) |
Qual: negative
Quant: < 0.09 kIU/L
Source: previous donation
|
< 115.00 kIU/L
|
Method: not specified System: Cobas Modular Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH344249
4.2 mL ($181.13)
Human K3EDTA plasma - Anti-cyclic citrullinated Peptide (CC... - E06.3
- Donor:
- Gender: Female Age: 20 Ethnic group: European/Caucasian
- Diagnosed disease:
- E06.3 - Autoimmune thyroiditis
- Medication:
- Amgevita
- Parameter:
- Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Donor:
- Gender:
- Female
- Age:
- 20 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 18 kg/m²
- Weight:
- 58 kg
- Height:
- 178 cm
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 1
Diseases:
- rheumatoid arthritis [E06.3]
Medication:
- Amgevita (Dosages: 40mg/2 weeks)
- L-thyroxine (Dosages: 50µg/day)
- Prednisolon (Dosages: 5mg, as needed)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) |
Qual: positive
Quant: 214 IU/mL
Source: previous donation
|
< 17.00 IU/mL
|
Method: not specified System: Cobas Roche |
| Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG |
Qual: positive
Quant: 284 U/mL
Source: this donation
|
< 17.00 U/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: Cobas 8000 Roche |
| Capsule-reactive protein (CRP) |
Qual: negative
Quant: 1.94 mg/L
Source: previous donation
|
< 5.00 mg/L
|
Method: not specified System: Modular Roche |
| Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) |
Qual:
Quant: 12 mm/1h
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Total Rheumatoid Factor (tRF) |
Qual: negative
Quant: < 10.00 IU/mL
Source: previous donation
|
< 14.00 IU/mL
|
Method: not specified System: Modular Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH240764
0.5 mL ($21.56)
Human K3EDTA plasma - Anti-cyclic citrullinated Peptide (CC... - E66.92
- Donor:
- Gender: Male Age: 55 Ethnic group: European/Caucasian
- Diagnosed disease:
- E66.92
- Medication:
- Metex
- Parameter:
- Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Donor:
- Gender:
- Male
- Age:
- 55 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 40 kg/m²
- Weight:
- 130 kg
- Height:
- 180 cm
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 1
Anamneses:
- acute phase reaction (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (increased CRP or normal BSS)
- duration of symptoms (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (Longer than 6 weeks)
- joint involvement (ACR/EULAR criteria) Score: 3 (4 to 10 small joints with or without involvement of big joints) (information given at the time of donation)
- serology (ACR/EULAR criteria) Score: 3 (information given at the time of donation) (high positive RF or ACPA)
- total points (ACR/EULAR criteria) 8 (information given at the time of donation)
- acute phase reaction (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (increased CRP or normal BSS)
- duration of symptoms (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (Longer than 6 weeks)
- joint involvement (ACR/EULAR criteria) Score: 3 (4 to 10 small joints with or without involvement of big joints) (information given at the time of donation)
- serology (ACR/EULAR criteria) Score: 3 (information given at the time of donation) (high positive RF or ACPA)
- total points (ACR/EULAR criteria) 8 (information given at the time of donation)
- acute phase reaction (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (increased CRP or normal BSS)
- duration of symptoms (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (Longer than 6 weeks)
- joint involvement (ACR/EULAR criteria) Score: 3 (4 to 10 small joints with or without involvement of big joints) (information given at the time of donation)
- serology (ACR/EULAR criteria) Score: 3 (information given at the time of donation) (high positive RF or ACPA)
- total points (ACR/EULAR criteria) 8 (information given at the time of donation)
- acute phase reaction (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (increased CRP or normal BSS)
- duration of symptoms (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (Longer than 6 weeks)
- joint involvement (ACR/EULAR criteria) Score: 3 (4 to 10 small joints with or without involvement of big joints) (information given at the time of donation)
- serology (ACR/EULAR criteria) Score: 3 (information given at the time of donation) (high positive RF or ACPA)
- total points (ACR/EULAR criteria) 8 (information given at the time of donation)
Diseases:
- E66.92
Medication:
- Metex (Dosages: 10mg/week)
- Prednisolon (Dosages: 1mg/day)
- Ramipril (Dosages: 5mg/day)
- bisoprolol (Dosages: 5mg/day)
- folic acid (Dosages: 5mg/week)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) |
Qual: positive
Quant: 316 IU/mL
Source: previous donation
|
< 17.00 IU/mL
|
Method: not specified System: Cobas Roche |
| Capsule-reactive protein (CRP) |
Qual: positive
Quant: 25.43 mg/L
Source: this donation
|
< 5.00 mg/L
|
Method: not specified System: Modular Roche |
| Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) |
Qual:
Quant: 35 mm/1h
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Total Rheumatoid Factor (tRF) |
Qual: positive
Quant: 265 IU/mL
Source: this donation
|
< 14.00 IU/mL
|
Method: not specified System: Modular Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH303758
1 mL ($43.13)
Human K2EDTA plasma - Anti-Thyroid peroxidase (aTPO / MAK),... - E05.0
- Donor:
- Gender: Female Age: 52 Ethnic group: European/Caucasian
- Medication:
- Forsteo
- Parameter:
- Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb)
Donor:
- Gender:
- Female
- Age:
- 52 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 25 kg/m²
- Weight:
- 71 kg
- Height:
- 170 cm
Sample:
- Matrix:
- K2EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Medication:
- Forsteo (acitve agent: teriparatide)
- Tianeurax (acitve agent: tianeptine)
- doxepin
- thiamazole (Dosages: 2.5mg/2 days)
Therapy:
- thyroid surgery
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual: positive
Quant: > 600.00 kIU/L
Source: previous donation
|
< 34.00 kIU/L
|
Method: not specified System: Cobas Modular Roche |
| TSH Receptor Antibodies (TRAb) |
Qual: positive
Quant: 17.5 IU/L
Source: previous donation
|
< 1.22 IU/L
Remarks: borderline: 1,22 - 1,75 |
Method: not specified System: Cobas Modular Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH322715
1 mL ($43.13)
Human K3EDTA plasma - Anti-cyclic citrullinated Peptide (CC... - I10.90
- Donor:
- Gender: Male Age: 57 Ethnic group: European/Caucasian
- Diagnosed disease:
- I10.90
- Medication:
- Metex
- Parameter:
- Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Donor:
- Gender:
- Male
- Age:
- 57 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 29 kg/m²
- Weight:
- 96 kg
- Height:
- 181 cm
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 1
Anamneses:
- acute phase reaction (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (increased CRP or normal BSS)
- duration of symptoms (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (Longer than 6 weeks)
- joint involvement (ACR/EULAR criteria) Score: 5 (More than 10 joints, at least one small joint) (information given at the time of donation)
- serology (ACR/EULAR criteria) Score: 3 (information given at the time of donation) (high positive RF or ACPA)
- total points (ACR/EULAR criteria) 10 (information given at the time of donation)
- acute phase reaction (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (increased CRP or normal BSS)
- duration of symptoms (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (Longer than 6 weeks)
- joint involvement (ACR/EULAR criteria) Score: 5 (More than 10 joints, at least one small joint) (information given at the time of donation)
- serology (ACR/EULAR criteria) Score: 3 (information given at the time of donation) (high positive RF or ACPA)
- total points (ACR/EULAR criteria) 10 (information given at the time of donation)
- acute phase reaction (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (increased CRP or normal BSS)
- duration of symptoms (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (Longer than 6 weeks)
- joint involvement (ACR/EULAR criteria) Score: 5 (More than 10 joints, at least one small joint) (information given at the time of donation)
- serology (ACR/EULAR criteria) Score: 3 (information given at the time of donation) (high positive RF or ACPA)
- total points (ACR/EULAR criteria) 10 (information given at the time of donation)
Diseases:
- I10.90
Medication:
- Metex (Dosages: 15mg/week)
- Olumiant (Dosages: 4mg/day, active agent: baricitinib)
- Ramipril (Dosages: 10mg/day)
- alendronic acid (Dosages: 70mg/week)
- amlodipine (Dosages: 10mg/day)
- folic acid (Dosages: 5mg/week)
- simvastatine (Dosages: 40mg/day)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) |
Qual: positive
Quant: > 500.00 IU/mL
Source: previous donation
|
< 17.00 IU/mL
|
Method: not specified System: Cobas Roche |
| Capsule-reactive protein (CRP) |
Qual: negative
Quant: 3.93 mg/L
Source: this donation
|
< 5.00 mg/L
|
Method: not specified System: Modular Roche |
| Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) |
Qual:
Quant: 25 mm/1h
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Total Rheumatoid Factor (tRF) |
Qual: positive
Quant: 99 IU/mL
Source: previous donation
|
< 14.00 IU/mL
|
Method: not specified System: Modular Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH303760
1 mL ($43.13)
Human EDTA plasma - Alkaline Phosphatase (ALP), Bilirubin... - K42.9
- Donor:
- Gender: Male Age: 78
- Diagnosed disease:
- K42.9 - Umbilical hernia without obstruction or gangrene
- Medication:
- Pantozol
- Parameter:
- Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb)
Donor:
- Gender:
- Male
- Age:
- 78 Years
- BMI:
- 27 kg/m²
- Weight:
- 78 kg
- Height:
- 170 cm
Sample:
- Matrix:
- EDTA plasma
- Condition:
- hemolytic
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Umbilical hernia without obstruction or gangrene [K42.9]
Medication:
- Pantozol (Dosages: 40mg)
- RamiLich
- lactulose
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual:
Quant: 98 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual:
Quant: 0.19 mg/dl
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual:
Quant: 8.1 not specified
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) |
Qual:
Quant: 21 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glucose |
Qual:
Quant: 102 mg/dl
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamate pyruvate transaminase (GPT / ALAT, ALT) |
Qual:
Quant: 11 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamic oxaloacetic transaminase (GOT / ASAT / AST) |
Qual:
Quant: 22 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 40 mmol/mol
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Hemoglobin (Hb) |
Qual:
Quant: 14.3 g/dl
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308314
0.4 mL ($17.25)
Human EDTA plasma - Alkaline Phosphatase (ALP), Amylase, ... - K40.0
- Donor:
- Gender: Male Age: 60
- Diagnosed disease:
- K40.0 - Bilateral inguinal hernia, with obstruction, without gangrene
- Medication:
- EnaHEXAL
- Parameter:
- Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Hemoglobin (Hb) Lipase
Donor:
- Gender:
- Male
- Age:
- 60 Years
- BMI:
- 31.1 kg/m²
- Weight:
- 92 kg
- Height:
- 172 cm
Sample:
- Matrix:
- EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Bilateral inguinal hernia, with obstruction, without gangrene [K40.0]
Medication:
- EnaHEXAL
- Simva (Dosages: 20mg)
- bisoprolol (Dosages: 5mg)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual:
Quant: 71 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Amylase |
Qual:
Quant: 30 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual:
Quant: 1.39 mg/dl
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual:
Quant: 4.9 not specified
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) |
Qual:
Quant: 56 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamate pyruvate transaminase (GPT / ALAT, ALT) |
Qual:
Quant: 46 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamic oxaloacetic transaminase (GOT / ASAT / AST) |
Qual:
Quant: 34 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Hemoglobin (Hb) |
Qual:
Quant: 16 g/dl
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Lipase |
Qual:
Quant: 41 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308315
0.4 mL ($17.25)
Human EDTA plasma - Alkaline Phosphatase (ALP), Amylase, ... - K86.1
- Donor:
- Gender: Male Age: 62
- Medication:
- Kreon
- Parameter:
- Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase
Donor:
- Gender:
- Male
- Age:
- 62 Years
- BMI:
- 22.5 kg/m²
- Weight:
- 73 kg
- Height:
- 180 cm
Sample:
- Matrix:
- EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Medication:
- Kreon
- insulin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual:
Quant: 82 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Amylase |
Qual:
Quant: 7 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual:
Quant: 0.49 mg/dl
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual:
Quant: 4.3 not specified
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) |
Qual:
Quant: 28 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 44 mmol/mol
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Hemoglobin (Hb) |
Qual:
Quant: 13.9 g/dl
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Lipase |
Qual:
Quant: 13 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308311
0.4 mL ($17.25)
Human EDTA plasma - Alkaline Phosphatase (ALP), Bilirubin... - C25.0
- Donor:
- Gender: Male Age: 51
- Diagnosed disease:
- C25.0 - Malignant neoplasm of head of pancreas - T2, M1, stage IV, non-resectable (not specified)
- Medication:
- Euthyrox
- Parameter:
- Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase ...
Donor:
- Gender:
- Male
- Age:
- 51 Years
- BMI:
- 44.8 kg/m²
- Weight:
- 142 kg
- Height:
- 178 cm
Sample:
- Matrix:
- EDTA plasma
- Condition:
- icteric
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of head of pancreas [C25.0] - T2, M1, stage IV, non-resectable (not specified)
Medication:
- Euthyrox
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual: positive
Quant: 681 U/L
Source: this donation
|
40-129 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual: positive
Quant: 12.3 mg/dl
Source: this donation
|
< 1 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual: positive
Quant: 1000 U/mL
Source: this donation
|
< 27 U/mL
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) |
Qual: positive
Quant: 1028 U/L
Source: this donation
|
Okt 71 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glucose |
Qual: positive
Quant: 180 mg/dl
Source: this donation
|
74 - 106 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamate pyruvate transaminase (GPT / ALAT, ALT) |
Qual: positive
Quant: 97 U/L
Source: this donation
|
Okt 50 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamic oxaloacetic transaminase (GOT / ASAT / AST) |
Qual: positive
Quant: 81 U/L
Source: this donation
|
Okt 50 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 32 mmol/mol
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Hemoglobin (Hb) |
Qual:
Quant: 11.3 g/dl
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Lipase |
Qual: positive
Quant: 65 U/L
Source: this donation
|
13 - 60 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Pancreatic Amylase |
Qual: negative
Quant: 22 U/L
Source: this donation
|
13 - 53 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308248
0.5 mL ($21.56)
Human K3EDTA plasma - Erythrocyte sedimentation rate (ESR) ... - J45.9
- Donor:
- Gender: Female Age: 52 Ethnic group: European/Caucasian
- Diagnosed disease:
- J45.9 - Asthma, unspecified
- Medication:
- Metex
- Parameter:
- Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total Rheumatoid Factor (tRF)
Donor:
- Gender:
- Female
- Age:
- 52 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 30 kg/m²
- Weight:
- 94 kg
- Height:
- 177 cm
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 1
Diseases:
- Asthma, unspecified [J45.9]
Medication:
- Metex (Dosages: 17.5mg/week)
- folic acid (Dosages: 5mg/week)
- sulfasalazine (Dosages: 1000mg/day)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) |
Qual: negative
Quant: < 8.00 IU/mL
Source: previous donation
|
< 17.00 IU/mL
|
Method: not specified System: Cobas Roche |
| Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG |
Qual: negative
Quant: < 7.00 U/mL
Source: this donation
|
< 17.00 U/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: Cobas 8000 Roche |
| Capsule-reactive protein (CRP) |
Qual: negative
Quant: 2.4 mg/L
Source: this donation
|
< 5.00 mg/L
|
Method: TIA (Turbidimetric Immuno Assay) System: Cobas 8000 Roche |
| Capsule-reactive protein (CRP) |
Qual: negative
Quant: 4.21 mg/L
Source: previous donation
|
< 5.00 mg/L
|
Method: not specified System: Modular Roche |
| Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) |
Qual:
Quant: 25 mm/1h
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Rheumatoid Factor (RF) IgM |
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
|
< 15.00 IU/mL
|
Method: TIA (Turbidimetric Immuno Assay) System: Cobas 8000 Roche |
| Total Rheumatoid Factor (tRF) |
Qual: negative
Quant: < 10.00 IU/mL
Source: previous donation
|
< 14.00 IU/mL
|
Method: not specified System: Modular Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH292294
1 mL ($43.13)
Human K3EDTA plasma - Anti-cyclic citrullinated Peptide (CC... - K76.0
- Donor:
- Gender: Female Age: 53 Ethnic group: European/Caucasian
- Diagnosed disease:
- K76.0 - Fatty (change of) liver, not elsewhere classified
- Medication:
- Metex
- Parameter:
- Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total Rheumatoid Factor (tRF)
Donor:
- Gender:
- Female
- Age:
- 53 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 32 kg/m²
- Weight:
- 78 kg
- Height:
- 156 cm
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 1
Diseases:
- Fatty (change of) liver, not elsewhere classified [K76.0]
Medication:
- Metex (Dosages: 7.5mg/week)
- Olumiant (Dosages: 4mg/day, active agent: baricitinib)
- folic acid (Dosages: 5mg/week)
- ibuprofen (Dosages: 800mg, as needed)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) |
Qual: positive
Quant: 197 IU/mL
Source: previous donation
|
< 17.00 IU/mL
|
Method: not specified System: Cobas Roche |
| Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG |
Qual: positive
Quant: 297 U/mL
Source: this donation
|
< 17.00 U/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: Cobas 8000 Roche |
| Capsule-reactive protein (CRP) |
Qual: negative
Quant: 0.3 mg/L
Source: previous donation
|
< 5.00 mg/L
|
Method: not specified System: Modular Roche |
| Capsule-reactive protein (CRP) |
Qual: negative
Quant: < 0.60 mg/L
Source: this donation
|
< 5.00 mg/L
|
Method: TIA (Turbidimetric Immuno Assay) System: Cobas 8000 Roche |
| Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) |
Qual:
Quant: 31 mm/1h
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Rheumatoid Factor (RF) IgM |
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
|
< 15.00 IU/mL
|
Method: TIA (Turbidimetric Immuno Assay) System: Cobas 8000 Roche |
| Total Rheumatoid Factor (tRF) |
Qual: negative
Quant: < 10.00 IU/mL
Source: previous donation
|
< 14.00 IU/mL
|
Method: not specified System: Modular Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH292324
1 mL ($43.13)
Human K3EDTA plasma - Anti-cyclic citrullinated Peptide (CC... - J30.1
- Donor:
- Gender: Female Age: 61 Ethnic group: European/Caucasian
- Diagnosed disease:
- J30.1 - Allergic rhinitis due to pollen
- Medication:
- Metex
- Parameter:
- Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total Rheumatoid Factor (tRF)
Donor:
- Gender:
- Female
- Age:
- 61 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 25 kg/m²
- Weight:
- 78 kg
- Height:
- 178 cm
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 1
Diseases:
- Allergic rhinitis due to pollen [J30.1]
Medication:
- Metex (Dosages: 15mg/week)
- folic acid (Dosages: 5mg/week)
- hydroxychloroquine (Dosages: 400mg/day)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) |
Qual: positive
Quant: 139 IU/mL
Source: this donation
|
< 17.00 IU/mL
|
Method: not specified System: Cobas Roche |
| Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG |
Qual: positive
Quant: 101 U/mL
Source: this donation
|
< 17.00 U/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: Cobas 8000 Roche |
| Capsule-reactive protein (CRP) |
Qual: negative
Quant: 0.8 mg/L
Source: this donation
|
< 5.00 mg/L
|
Method: TIA (Turbidimetric Immuno Assay) System: Cobas 8000 Roche |
| Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) |
Qual:
Quant: 9 mm/1h
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Rheumatoid Factor (RF) IgM |
Qual: positive
Quant: 35 IU/mL
Source: this donation
|
< 15.00 IU/mL
|
Method: TIA (Turbidimetric Immuno Assay) System: Cobas 8000 Roche |
| Total Rheumatoid Factor (tRF) |
Qual: positive
Quant: 33 IU/mL
Source: this donation
|
< 14.00 IU/mL
|
Method: not specified System: Modular Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH292438
1 mL ($43.13)
